Email bulletins

Archive

November 2014

  • News from The Liver Meeting
  • Interferon-free treatment: sofosbuvir/ledipasvir
  • Decompensated cirrhosis
  • HIV and hepatitis C co-infection
  • Interferon-free treatment: other regimens for HCV genotype 1
  • A single interferon-free treatment for multiple genotypes?
  • Interferon-free treatment for genotype 4 infection
  • Survival
  • AbbVie '3D' interferon-free combination receives scientific approval in European Union
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

October 2014

  • Cost and access issues
  • Harvoni approved in US
  • Petition for improved HCV diagnosis and treatment for people in Europe who use drugs
  • Egypt infection control
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

September 2014

  • Daclatasvir (Daklinza) approved in the EU
  • Universal access to hepatitis C treatment in the EU
  • Access to hepatitis C treatment outside the EU and US
  • US insurance restrictions and barriers to treatment
  • Pricing of sofosbuvir / ledipasvir
  • First European Conference on hepatitis C and harm reduction
  • Hepatitis C treatment factsheets
  • Is this your copy of the infohep news bulletin?

July 2014

  • Daclatasvir recommended for European approval
  • Hepatitis C treatment during opioid substitution therapy
  • Hepatitis C treatment for people with HIV and hepatitis C co-infection
  • Hepatitis C treatment factsheets
  • Customise your hepatitis information
  • Is this your copy of the infohep news bulletin?

June 2014

  • Disease and healthcare utilisation burden without treatment
  • Recent European decisions on reimbursement for sofosbuvir treatment of hepatitis C
  • Merck buys Idenix to improve its hepatitis C portfolio
  • BMS aims to test four-week treatment course for HCV
  • Faldaprevir discontinued
  • Achillion development plans
  • Getting ready for World Hepatitis Day?
  • New! Hepatitis C treatment factsheets
  • New! Customise your hepatitis information
  • Is this your copy of the infohep news bulletin?

May 2014

  • Simeprevir marketing approval
  • Hepatitis B screening recommendations
  • Sofosbuvir for treatment of genotype 4 hepatitis C
  • Sofosbuvir for treatment of post-transplant hepatitis C recurrence
  • US health insurers question the price of sofosbuvir
  • New! Hepatitis C treatment factsheets
  • New! Customise your hepatitis information
  • Is this your copy of the infohep news bulletin?

April 2014

  • New European treatment guidelines for hepatitis C
  • World Health Organization issues treatment guidelines for hepatitis C
  • Access
  • Hepatitis C treatment news from the International Liver Congress
  • Prevention of hepatitis C infection
  • Hepatitis B treatment
  • Hepatitis delta treatment
  • New! Hepatitis C treatment factsheets
  • New! Customise your hepatitis information
  • Is this your copy of the infohep news bulletin?

March 2014

  • Shorter treatment is possible for hard-to-treat patients
  • Simeprevir – new HCV protease inhibitor
  • AbbVie '3D' combination highly potent treatment for genotype 1b infection
  • HIV co-infection
  • Other interferon-free combinations on the way
  • European policy
  • Cost of treatment
  • Access to treatment
  • Egypt negotiates 99% discount on sofosbuvir price
  • Forthcoming events
  • Is this your copy of the infohep news bulletin?

February 2014

  • Access to hepatitis C treatment
  • Treat or wait?
  • AbbVie completes interferon-free trials programme
  • Gilead seeks approval for ledipasvir/sofosbuvir combination tablet
  • Hepatitis C stroke risk
  • Hepatitis B screening guidelines in US
  • Is this your copy of the infohep news bulletin?

January 2014

  • New US hepatitis C treatment guidelines
  • New European hepatitis C treatment guidelines
  • Sofosbuvir approval in European Union
  • Sofosbuvir/ledipasvir results
  • Daclatasvir filing in European Union
  • Other new drugs news
  • Is your organisation listed in the infohep services database?